According to the Center for the Safety of Pharmaceutical Products, the amount of hydrochlorothiazide in the C2501976 series of the drug "Telsartan H 80 mg/12.5 mg" manufactured by India's "Dr. Reddy's Laboratories Ltd" has deviated from the established norm. Consequently, this series of the drug is being recalled from circulation.
No non-conformity has been identified in the C2501977 series, but as a precautionary measure, it is also being withdrawn from the market. Citizens are advised not to use this drug and, if necessary, to choose an alternative medication after consulting a doctor.
The Center urges the public to handle medications based on information verified from official sources.
